It has been reported that there is an age-dependent increase in the Treg : CD8+ ratio, with a maximal increase in the 60–69 years age group, which coincides with the median age (64 years) of GBM patients at diagnosis (218). This evidence concerns the gene CD8A and glioblastoma.